March 5, 2025- Our collaboration effort on developing an “off-the-shelf” CAR-NKT cell therapy for ovarian cancer, together with UCLA Clinician Dr. Sanaz Memarzadeh, Bioinformatician Dr. Matteo Pellegrini, and Biostatistician Dr. Jin Zhou, is featured on various UCLA News. Game on! […]
February 29, 2025- Our Postdoctoral Scholar, Charlie Yan-Ruide Li, is awarded the 2025 UCLA Goodman-Luskin Microbiome Center Collaborative Research Fellowship. This fellowship is awarded to outstanding trainees and early-stage investigators exploring microbiome research. Congratulations! June 14, 2024- Our Postdoctoral Scholar, […]
May 30, 2024- Dr. Lili Yang receives a $6.3 million CIRM Partnering Opportunity for Translational Research Projects Award to translate a novel stem cell-engineered off-the-shelf CAR-NKT cell therapy for ovarian cancer into clinics. [Link][PDF] May 18, 2021- Dr. Lili Yang […]
We are currently recruiting PhD students (2 openings) and postdoctoral researchers (1 opening). Welcome to apply! [PhD Openings][Postdoc Openings]
May 11, 2021- Our off-the-shelf cell therapy technology is licensed by a Biotech startup, Appia Bio, for commercial development. The company launches with $52 million Series A financing. [Appia News][Endpoints News] August 5, 2021- Appia Bio and Kite announce collaboration […]
